A highly efficient transgene knock-in technology in clinically relevant cell types

Alexander G. Allen(Institute for Molecular Medicine), John A. Zuris(Howard Hughes Medical Institute), Ramya Viswanathan(Editas Medicine (United States)), Eugenio Marco(Editas Medicine (United States)), Carl S. Holland(Editas Medicine (United States)), Sean Scott(Editas Medicine (United States)), Meng Wu(Mayo Clinic), Swarali Surendra Lele(Editas Medicine (United States)), Georgia Giannoukos(Editas Medicine (United States)), John A. Follit(University of Massachusetts Chan Medical School), Michael Nehil(Editas Medicine (United States)), Deric Zhang(Editas Medicine (United States)), Samia Khan(Jamia Hamdard), Patrizia Mazzucato(Center for Environmental Health), Yan Huang(Sichuan Agricultural University), Laura Blaha(Editas Medicine (United States)), Kaitlyn M. Izzo(Editas Medicine (United States)), Stephen E. Sherman(Editas Medicine (United States)), Christopher J. Wilson, Xiaoqi Sun(University of Chinese Academy of Sciences), Alexandra Gerew(Editas Medicine (United States)), Rithu Pattali(University of California, Berkeley), Michael Jaskolka(Editas Medicine (United States)), Jacqueline D. Nelson(Editas Medicine (United States)), Carrie M. Margulies(Center for Environmental Health), Peisheng Zhang(Editas Medicine (United States)), Dawn Ciulla(Broad Institute), Aaron Wilson(Pathways Behavioral Services), Kai‐Hsin Chang(National Taiwan University), Mark S. Shearman(Editas Medicine (United States)), Nadire R. Cochran, Amy H. Zhao(Editas Medicine (United States))

Nature Biotechnology

May 1, 2023

Cited by 66

Related Papers

|Nature|2012|12k

|Nature|2012|8.5k

|Nature|2007|4.2k

|Genome Research|2011|3.6k

|Nature|2012|2.8k